CHRS offering history
Every offering-related filing in Coherus Oncology, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 915 filings back to Feb 23, 2011.
| Date | Filing | What it means | |
|---|---|---|---|
| Feb 13, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Feb 12, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jan 23, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Dec 8, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Nov 13, 2025 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Oct 6, 2023 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Sep 12, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jul 26, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jul 26, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 17, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 16, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Nov 18, 2022 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Nov 17, 2022 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Nov 8, 2022 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Feb 2, 2021 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Apr 17, 2020 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 23, 2018 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 21, 2018 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 7, 2018 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 4, 2018 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Jan 25, 2018 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Dec 5, 2017 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Oct 16, 2017 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Sep 22, 2017 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Aug 22, 2017 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Feb 8, 2017 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Feb 7, 2017 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Oct 28, 2016 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 24, 2016 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 23, 2016 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Feb 29, 2016 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jan 21, 2016 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Dec 18, 2015 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Sep 14, 2015 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Apr 1, 2015 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Mar 31, 2015 | S-1MEF → | REGISTERED | S-1MEF registration — capacity to sell shares, not a sale yet |
| Mar 31, 2015 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Mar 30, 2015 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Mar 23, 2015 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Mar 11, 2015 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
CHRS offering FAQ
When did CHRS last execute an offering?
Per SEC filings, Coherus Oncology, Inc.'s most recent priced offering document is a 424B5 filed 2026-02-13. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did CHRS last announce or register an offering?
The most recent registration is a S-3 filed 2025-11-13. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.